Find a Trial
Trial Results
7 protocol(s) meet the specified criteria
CTO-CAEL101-301OPEN TO ACCRUAL
CTO-CAEL101-302OPEN TO ACCRUAL
CTO-EAA173OPEN TO ACCRUAL
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
CTO-FT576-101OPEN TO ACCRUAL
A Phase I Study of FT576 as Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma
CTO-MT-0169-001OPEN TO ACCRUAL
A Phase 1, Open-Label, Dose-Escalation, Multicenter Study to Evaluate the Safety,
Tolerability, Pharmacokinetics, and Efficacy of TAK-169 in Patients With Relapsed or
Refractory Multiple Myeloma
CTO-TAK-981-1503OPEN TO ACCRUAL
A Phase 1b/2 Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of TAK-981 in Combination With Monoclonal Antibodies in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
IUSCC-0633OPEN TO ACCRUAL
Prospective Observation of the Incidence and Natural History of Monoclonal Gammopathy in Patients Undergoing Weight Reduction Surgery